Work

A Multicenter Double-Blind Study of Three Different Doses of the New cAMP-Phosphodiesterase Inhibitor Rolipram in Patients with Major Depressive Disorder

Year: 2008

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Neuropsychobiology

DOI: 10.1159/000118897

Authors: W.W. Fleischhacker, H. Hinterhuber, H. Bauer, B. Pflug, P. Berner, C. Simhandl, R. Wolf, W. Gerlach, H. Jaklitsch, M. Sastre-y-Hernández, H. Schmeding-Wiegel, B. Sperner-Unterweger, B. Voet, H. Schubert

Institutions: Innsbruck Medical University, Universität Innsbruck, University Hospital Innsbruck, Goethe University Frankfurt, University of Vienna

Language: English

Topic: Treatment of Major Depression

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1969819088

FWCI: 6.778

Cites:

Cited by: 149

Related to: 10